Libertyville, IL, United States of America

Jay R Luly

USPTO Granted Patents = 61 



Average Co-Inventor Count = 3.3

ph-index = 16

Forward Citations = 965(Granted Patents)


Inventors with similar research interests:


Location History:

  • Lake Bluff, IL (US) (1987)
  • Liverty Ville, IL (US) (1995)
  • Libertyville, IL (US) (1987 - 1998)
  • Wellesley, MA (US) (2000 - 2018)

Company Filing History:


Years Active: 1987-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chemokine Receptor Antagonists
Therapeutic Compounds
Deuterated Nucleoside Derivatives
Imidazolidine Compounds
Macrocyclic Immunomodulators
Anaphylatoxin Receptor Ligands
Substituted Quinoxaline Derivatives
Glucocorticoid-Selective Agents
Macrolide Immunomodulators
Thio-Heterocyclic Macrolactam Immunomodulators
Hexapeptide Anaphylatoxin-Receptor Ligands
Peptidylaminodiols
61 patents (USPTO):Explore Patents

Title: Jay R Luly: A Pioneer in Pharmaceutical Innovations

Introduction

Jay R Luly, based in Libertyville, IL, is a prominent figure in the pharmaceutical industry, recognized for his significant contributions to drug development. With an impressive portfolio of 61 patents, Luly has made substantial advancements in creating compounds aimed at treating viral infections, amongst other pharmaceutical applications.

Latest Patents

Among his latest innovations, Luly has developed compounds represented by specific formulas that include pharmaceutically acceptable salts, esters, stereoisomers, tautomers, solvates, and combinations thereof. These compounds have been designed for treating viral infections in subjects. Additionally, he has introduced deuterated nucleoside/tide derivatives, providing nucleoside phosphoramidate compounds and pharmaceutical compositions which offer methods of use for tackling viral infections.

Career Highlights

Throughout his career, Jay R Luly has collaborated with leading organizations, including Abbott Laboratories Corporation. His expertise and innovative approach have allowed him to contribute to the development of effective pharmaceutical solutions, impacting the medical field significantly.

Collaborations

Luly has worked alongside esteemed colleagues such as Yat Sun Or and Megumi Kawai. Their collective efforts have fueled innovations in the pharmaceutical landscape, as they strive to develop advanced treatments for critical health issues.

Conclusion

With a strong focus on innovation and collaboration, Jay R Luly continues to push the boundaries of pharmaceutical science. His extensive patent portfolio reflects his commitment to advancing healthcare solutions and addressing the challenges posed by viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…